A detailed history of Farther Finance Advisors, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 11 shares of WVE stock, worth $148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 11 -0.0%
Holding current value
$148
Previous $58,000 55.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$4.38 - $6.48 $65 - $97
-15 Reduced 57.69%
11 $58,000
Q1 2024

May 13, 2024

SELL
$3.54 - $6.84 $77 - $150
-22 Reduced 45.83%
26 $164,000
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $199 - $329
48 New
48 $242,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.